New Blood Test Improves Tuberculosis Diagnosis
New Blood Test Improves Tuberculosis Diagnosis
Tuberculosis (TB) remains a major global health challenge, causing over a million deaths annually.
For decades, diagnosis has relied on "sputum-based tests"[0|18|26|type:method] or "skin tests"[27|38|type:method], which are often slow, difficult to administer, or unable to distinguish between latent and active infection.
However, a significant shift in the medical landscape is underway as researchers develop new "blood-based assays"[39|60|type:innovation].
These innovative tests aim to overcome the limitations of older methods by using advanced techniques like "CRISPR-based diagnostics"[61|87|type:technology] to detect bacterial "cell-free DNA"[88|103|type:biomarker] directly in the blood.
Unlike current standards, such as the "IGRA"[104|108|type:test], these new tools promise rapid results, often in under an hour, which is crucial for stopping transmission.
